中华医学遗传学杂志
中華醫學遺傳學雜誌
중화의학유전학잡지
CHINESE JOURNAL OF MEDICAL GENETICS
2012年
3期
249-254
,共6页
刘敏娟%谢敏%毛君%李红%严文华%陈瑛
劉敏娟%謝敏%毛君%李紅%嚴文華%陳瑛
류민연%사민%모군%리홍%엄문화%진영
假肥大型肌营养不良%DMD基因%基因诊断%第2代测序
假肥大型肌營養不良%DMD基因%基因診斷%第2代測序
가비대형기영양불량%DMD기인%기인진단%제2대측서
Duchenne/Becker muscular dystrophy%DMD gene%Gene diagnosis%Next-generation sequencing
目的 对假肥大型肌营养不良患者进行基因检测.方法 采用目标区序列捕获及第2代高通量测序技术对6例假肥大型肌营养不良患者进行检测;采用第1代测序技术、多重连接依赖的探针扩增技术(multiplex ligation-dependent probe amplification,MLPA)对患者及其母亲的基因型进行验证.结果 1例为第10和11外显子缺失,1例为第16和17外显子重复,4例为点突变.共发现10种变异:c.2776C>T、c.5475delA、c.6391_ 6392delCA、IVS64+1G>A、c.2645A>G、c.5244G>A、c.7728T>C、c.8729A>T、e.8734A>G和c.8810G>A,前4种为可疑致病性变异,后6种为人群中的多态.其中3例为首次发现的新突变(IVS64+1G>A、c.6391_6392delCA(p.Q2131NfsX3)和p.Q926X(CAG>TAG).结论 通过第2代测序技术可以在一个反应中准确检测出DMD基因的缺失、重复和点突变,具有一定的临床应用价值.
目的 對假肥大型肌營養不良患者進行基因檢測.方法 採用目標區序列捕穫及第2代高通量測序技術對6例假肥大型肌營養不良患者進行檢測;採用第1代測序技術、多重連接依賴的探針擴增技術(multiplex ligation-dependent probe amplification,MLPA)對患者及其母親的基因型進行驗證.結果 1例為第10和11外顯子缺失,1例為第16和17外顯子重複,4例為點突變.共髮現10種變異:c.2776C>T、c.5475delA、c.6391_ 6392delCA、IVS64+1G>A、c.2645A>G、c.5244G>A、c.7728T>C、c.8729A>T、e.8734A>G和c.8810G>A,前4種為可疑緻病性變異,後6種為人群中的多態.其中3例為首次髮現的新突變(IVS64+1G>A、c.6391_6392delCA(p.Q2131NfsX3)和p.Q926X(CAG>TAG).結論 通過第2代測序技術可以在一箇反應中準確檢測齣DMD基因的缺失、重複和點突變,具有一定的臨床應用價值.
목적 대가비대형기영양불량환자진행기인검측.방법 채용목표구서렬포획급제2대고통량측서기술대6례가비대형기영양불량환자진행검측;채용제1대측서기술、다중련접의뢰적탐침확증기술(multiplex ligation-dependent probe amplification,MLPA)대환자급기모친적기인형진행험증.결과 1례위제10화11외현자결실,1례위제16화17외현자중복,4례위점돌변.공발현10충변이:c.2776C>T、c.5475delA、c.6391_ 6392delCA、IVS64+1G>A、c.2645A>G、c.5244G>A、c.7728T>C、c.8729A>T、e.8734A>G화c.8810G>A,전4충위가의치병성변이,후6충위인군중적다태.기중3례위수차발현적신돌변(IVS64+1G>A、c.6391_6392delCA(p.Q2131NfsX3)화p.Q926X(CAG>TAG).결론 통과제2대측서기술가이재일개반응중준학검측출DMD기인적결실、중복화점돌변,구유일정적림상응용개치.
[Objective]To detect genetic causes of Duchenne muscular dystrophy(DMD).[Methods] Next-generation sequencing was used to detect 6 DMD patients in whom no exonic deletions were detected by multiplex PCR.Sanger sequencing and multiplex ligation-dependent probe amplification were used to confirm the results.[Results] One case was found to have deletions of exons 10 and 11,1 had exons 16 and 17 duplication,4 cases have 8 point mutations including c.2776C>T,c.5475delA,c.6391_6392delCA,IVS64+ 1G>A,c.2645A>G,c.5244G>A,c.7728T>C,c.8729A>T,c.8734A>G and c.8810G>A.The former 4 mutations are auspicious pathogenicity,the other 6 mutations are polymorphism in population.Three novel mutations (IVS64+ 1G>A,c.6391_6392delCA (p.Q2131NfsX3) and p.Q926X (CAG>TAG) were not reported before.[Conclusion] Next-generation sequencing technology is a useful tool for the detection of deletion,duplication and point mutation,which is valuable for clinical application.